Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

PPLPHARMA - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Technical List

Technical Rating: 3.1

Here’s a detailed technical breakdown of Piramal Pharma Ltd. (₹206) based on current indicators and chart patterns

📊 Trend Analysis

Current Trend: Consolidating with mild bullish bias

Price Action: Hovering around 50-DMA (₹206) and slightly below 200-DMA (₹209) — suggests indecision.

RSI (50.2): Neutral zone — no strong momentum.

MACD (0.47): Slightly positive — early signs of bullish crossover.

Volume: Significantly above 1-week average — indicates strong activity, possibly accumulation.

📈 Moving Averages

Indicator Value (₹) Signal

50-DMA 206 Neutral (Price ≈ DMA)

200-DMA 209 Bearish (Price < DMA)

📉 Momentum Indicators

RSI: 50.2 — neutral, watch for breakout above 55 for bullish confirmation.

MACD: Slightly positive — early bullish signal.

Bollinger Bands: Price likely near middle band — consolidation phase.

🔍 Volume Trends

Current Volume: 1.61 crore

1W Avg Volume: 64.3 lakh

Interpretation: Surge in volume suggests strong interest, possibly institutional activity.

📌 Support & Resistance Zones

Level Price (₹)

Support 1 200

Support 2 185

Resistance 1 209 (200-DMA)

Resistance 2 225

Resistance 3 250

🎯 Entry & Exit Strategy

Optimal Entry Zone: ₹200–₹206 (near support and 50-DMA)

Exit Zone: ₹225–₹250 (resistance levels)

Stop Loss: ₹185 (below key support)

🧭 Conclusion

Trend: Consolidating with mild bullish undertone

Momentum: Neutral, but volume spike hints at potential breakout

Recommendation: Watch for breakout above ₹209 with volume confirmation. Ideal for short-term swing trade if ₹200 support holds.

You can explore live technical charts and signals on TradingView’s PPLPHARMA page or Trendlyne’s technical dashboard

1

2

. Want to compare it with other pharma stocks or dive into its earnings volatility next?

1

in.tradingview.com

2

trendlyne.com

Edit in a page

Back to Technical List